Cognition Therapeutics (CGTX) Social Stream
COGNITION THERAPEUTICS INC (CGTX) Price Targets From Analysts
Use the tables below to see what analysts covering COGNITION THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-23 | 1 | $22 | $22 | $22 | $1.93 | 1039.9% |
| 2021-11-30 | 2 | $27 | $22 | $24.5 | $1.93 | 1169.43% |
| 2022-01-21 | 2 | $22 | $20 | $21 | $1.93 | 988.08% |
| 2022-03-31 | 2 | $20 | $18 | $19 | $1.93 | 884.46% |
| 2022-04-01 | 2 | $18 | $15 | $16.5 | $1.93 | 754.92% |
| 2022-08-11 | 3 | $18 | $10 | $14.333 | $1.93 | 642.64% |
| 2022-09-29 | 4 | $18 | $10 | $13.75 | $1.93 | 612.44% |
| 2022-11-21 | 4 | $15 | $9 | $11.5 | $1.93 | 495.85% |
| 2022-11-23 | 3 | $15 | $9 | $11 | $1.93 | 469.95% |
| 2022-12-16 | 4 | $15 | $9 | $11 | $1.93 | 469.95% |
| 2023-02-08 | 4 | $15 | $8 | $10.5 | $1.93 | 444.04% |
| 2023-03-26 | 4 | $15 | $7 | $10.25 | $1.93 | 431.09% |
| 2023-08-08 | 4 | $10 | $5 | $7.75 | $1.93 | 301.55% |
| 2023-08-11 | 4 | $10 | $5 | $7.25 | $1.93 | 275.65% |
| 2023-11-09 | 4 | $9 | $5 | $6.25 | $1.93 | 223.83% |
The Trend in the Analyst Price Target
Over the past 26 weeks, CGTX's average price target has gone down $1.5.
Over the past 42 weeks, CGTX's average upside potential has been 413.73%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-13 | 4 | 15 | 7 | 10.250 | 1.81 | 466.3% |
| 2023-04-13 | 4 | 10 | 5 | 7.750 | 1.79 | 332.96% |
| 2023-05-10 | 4 | 10 | 5 | 7.750 | 1.57 | 393.63% |
| 2023-08-11 | 4 | 10 | 5 | 7.250 | 1.60 | 353.12% |
| 2023-11-09 | 4 | 9 | 5 | 6.666 | 1.00 | 566.6% |
CGTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CGTX's average broker recommendation rating improved by 0 over the prior 18 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CGTX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, COGNITION THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1790.5% of them.
- In the context of all US stocks, COGNITION THERAPEUTICS INC's number of analysts covering the stock is higher than 163.91% of them.
- To contextualize these metrics, consider that out of all US stocks, COGNITION THERAPEUTICS INC's average analyst price target is higher than 313.19% of them.
- In the context of stocks in the micro market cap category, COGNITION THERAPEUTICS INC's variance in analysts' estimates is lower than -998.91% of them.
In the Pharmaceutical Products industry, OKYO, MNPR, and CNSP are the three stocks most similar to COGNITION THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CGTX a Buy, Hold or Sell? See the POWR Ratings now!